Protocol for Women at Increased Risk of Developing Breast Cancer

Description

The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.

Conditions

Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Protocol for Women at Increased Risk of Developing Breast Cancer

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Kansas City

University of Kansas Medical Center, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * women with at least 2 times the normal risk of developing breast cancer
  • * between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative)
  • * greater than six months from ingestion of antihormonal therapy
  • * greater than 1 year from pregnancy, lactation, or chemotherapy
  • * willing to have a mammogram within six months prior to RPFNA
  • * willing to discontinue NSAIDS or herbal supplements
  • * willing to have blood drawn
  • * no metastatic malignancy of any kind
  • * no breast implants or tram flap reconstructions
  • * no radiation to both breasts
  • * no women who have a current mammogram or clinical breast exam suspicious for cancer

Ages Eligible for Study

30 Years to 65 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Carol Fabian, MD,

Carol J Fabian, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2026-12